Advisory Panel

Representing a broad cross section of the various global stakeholders in the development and use of TB drug regimens, the Advisory Panel informs CPTR’s general policy and decision-making process. Panel members work directly with CPTR Coordinating Group— the Initiative’s overall steering body—to help CPTR navigate the complicated technical, political, and economic challenges that challenge the field of TB drug development. Members will also help catalyze global support for TB drug combination testing and champion the pathways and other tools needed to accelerate the development and delivery of dramatically improved treatment to TB patients worldwide.

Members include: